{"id":348459,"date":"2026-10-31T11:25:45","date_gmt":"2026-10-31T06:25:45","guid":{"rendered":"https:\/\/sapeher.dailysapehertimes.com.pk\/?p=348459"},"modified":"2026-10-31T11:25:45","modified_gmt":"2026-10-31T06:25:45","slug":"islamabad-sapeher-times-safeguarding-access-to-insulin-availability-alone-is-not-enough","status":"publish","type":"post","link":"https:\/\/sapeher.dailysapehertimes.com.pk\/?p=348459","title":{"rendered":"ISLAMABAD (Sapeher Times) Safeguarding Access to Insulin: Availability Alone Is Not Enough"},"content":{"rendered":"<p>ISLAMABAD (Sapeher Times) The reported disruption in the supply of Apidra has raised an urgent question for patients who rely on prescribed insulin to manage their condition. In October 2026, the Ministry of National Health Services and the Drug Regulatory Authority of Pakistan (DRAP) stepped forward to clarify that the problem is strictly limited to insulin glulisine, sold under the brand name Apidra, and does not represent a nationwide shortage of all insulin products. According to health authorities, alternative rapid-acting insulin analogues, including NovoRapid and Humalog, remain available nationwide. However, this administrative clarification does little to ease the immediate anxiety of patients who use Apidra; they have been strongly advised to consult their doctors before changing treatment, as switching insulin formulations requires careful clinical dose adjustment and strict individual monitoring.<\/p>\n<p>The Chasm Between Availability and Access<\/p>\n<p>While the official clarification from health regulators is welcome, it does not remove the steep practical difficulty of finding a seamless, appropriate replacement in real-time. A substitute listed as available on paper is of little practical use if a vulnerable patient cannot physically obtain it or afford it at the pharmacy counter. This disruption highlights a deeper structural crack in the safety net: health authorities must move beyond reactionary press releases and actively publish timely, transparent information about supply chain disruptions. Furthermore, public policy must dictate where affected patients can immediately obtain clinical guidance, and public hospitals must be equipped with dedicated support channels to help patients navigate alternative treatments safely and without bureaucratic delay.<\/p>\n<p>A Broad Public Health Emergency<\/p>\n<p>With an estimated 33 million to 34.5 million people living with diabetes in Pakistan, and more than one million citizens relying directly on daily insulin for survival, continuity of treatment must be treated as a critical matter of public health, not merely a backend supply-chain issue. The economic realities further complicate this crisis, as past data shows that market deregulation can drive up median insulin prices by over 31 per cent, pricing vulnerable households out of life-saving care. When supply chains fracture, local production and alternative brands can only stabilize the market if they are paired with strict public procurement and transparent price monitoring. The government must take absolute responsibility to ensure that patients can easily obtain medical advice and continue their insulin therapy safely, affordably, and completely uninterrupted.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>ISLAMABAD (Sapeher Times) The reported disruption in the supply of Apidra has raised an urgent question for patients who rely on prescribed insulin to manage their condition. In October 2026, the Ministry of National Health Services and the Drug Regulatory Authority of Pakistan (DRAP) stepped forward to clarify that the problem is strictly limited to [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":348458,"comment_status":"","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[63,7],"tags":[],"class_list":["post-348459","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-63","category-pakistan-news"],"_links":{"self":[{"href":"https:\/\/sapeher.dailysapehertimes.com.pk\/index.php?rest_route=\/wp\/v2\/posts\/348459","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sapeher.dailysapehertimes.com.pk\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sapeher.dailysapehertimes.com.pk\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sapeher.dailysapehertimes.com.pk\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/sapeher.dailysapehertimes.com.pk\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=348459"}],"version-history":[{"count":0,"href":"https:\/\/sapeher.dailysapehertimes.com.pk\/index.php?rest_route=\/wp\/v2\/posts\/348459\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sapeher.dailysapehertimes.com.pk\/index.php?rest_route=\/wp\/v2\/media\/348458"}],"wp:attachment":[{"href":"https:\/\/sapeher.dailysapehertimes.com.pk\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=348459"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sapeher.dailysapehertimes.com.pk\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=348459"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sapeher.dailysapehertimes.com.pk\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=348459"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}